Xi`an Eastling Biotech Co., Ltd.
Diamond Supplier
- Diamond
Supplier - 1st
years
Diamond Supplier
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Lab/Research institutions
Tel: +86-156-91766041
Mobile:
Tel: +86-156-91766041
Fax:
URL: http://www.eastlingbiotech.com/
Province/state: Shaanxi
City: Xi'an city
Street: No. 201, Unit 4, Building 9, Hongqi Community, Tanjia Street, Weiyang District, Xi 'an, Shaanxi
MaxCard:
Contact Suppliers
CAS NO.37312-62-2
98%(500-1000)Kilogram98%(100-500)Metric Ton
| Name | Serratiopeptidase |
| Synonyms | dasen SERRATIOPEPTIDASE Serratiopeptidase SerratiopeptidaseSerrapeptase serratiaextracellularproteinase proteinase,serratiaextracellular |
| CAS | 37312-62-2 |
| EINECS | 253-457-5 |
| Molecular Formula | ICl |
| Use | Serrapeptidase was found to have the ability of protein dissolution, which can inhibit the inflammatory substances, and is often used as a phlegm and pus medicine. At the same time, serrapeptidase also promotes the regeneration of cells and promotes the healing of wounds, when used with antibiotics, there is a synergistic effect to improve the antibacterial effect of antibiotics. So it is a good choice for traumatic drugs. |
Abstract:
serrapeptidase is a potent expectorant, anti-inflammatory and detumescence multiple role of enzyme preparations, can quickly break down denatured protein, bradykinin and cellulose clots, the pus, sputum, blood clots and other liquefaction thinning, easy drainage, accelerate wound purification, promote granulation tissue new life. Widely used in clinical phlegm and swelling. This article reviews the pharmacological action and clinical application of serrapeptidase.
Key words:
respiratory disease serrapeptidase Anti-inflammatory detumescence expectorant
DOI:
CNKI:SUN:XYYL.0.2008-08-020
cited:
year:
2008
Last Update：2024-01-02 23:10:35
invention patent
Application (patent) number:
CN201711453142.3
application date:
20171228
Public/Announcement Number:
CN108078963A
Public/announcement date:
20180529
applicant (patent):
Zhengzhou Assisted Living Science and Technology Co., Ltd.
inventor:
National and provincial code:
CN410102
Abstract:
A serrapeptidase preparation, including, but not limited to, inhalation powder aerosol, Inhalation Aerosol. Said serrapeptidase inhalation preparation, wherein the serrapeptidase is micronized, has a particle size distribution in the range of 1100 μm, preferably 350 μm. The serrapeptidase preparation is administered by inhalation, and is used for inflammation, edema and expectoration difficulty caused by various respiratory diseases.
objective to study the clinical application value of Budesonide Nasal Spray combined with Serrapeptase Enteric-coated Tablets in the treatment of allergic rhinitis. Methods from October 2007 to October 2010, 150 patients with allergic rhinitis were diagnosed in the Department of Otolaryngology in our hospital. The patients were randomly divided into budesonide group, serrapeptidase group and combination group, 50 cases in each group. Budesonide group was treated with 1 spray of drug from Budesonide Nasal Spray pair of nasal spray on each side every morning and evening for 4 weeks; Serrapeptidase group was treated with oral administration of Serrapeptase Enteric-coated Tablets 10 mg, 3 times/d, for 7 days; in the combination group, Budesonide Nasal Spray and Serrapeptase Enteric-coated Tablets were used at the same dose and duration as in the previous two groups. The disease symptoms, signs scores and adverse drug events were recorded before and after treatment, and the curative effects of the three groups were compared. Results after treatment, the combined drug group IL-9,IL-13 content was significantly lower than that of budesonide group and serrapeptidase group [(17.4±5.9) ng/L vs (48.4±9.1)ng/L,(46.3±7.9) ng/L; (200.9±42.8) ng/L (310.4±68.4) ng/L,(268.9±61.2) ng/L, the difference was statistically significant (F = 22.46, comparison of total effective rate of three groups, budesonide group [0.05 (31/50)] and serrapeptidase group [62% (30/50)] compared with the combination group [80% (40/50)], the differences were statistically significant (x2 = 8.73,7.89, all P<0.05), there was no significant difference between budesonide group and serrapeptidase group (x2 = 0.21,P>0.05). Conclusion The combination of Budesonide Nasal Spray and serrapeptidase tablets has good stability and good tolerance, which can control the onset of allergic rhinitis, improve the quality of life and improve the prognosis, it is worthy of clinical application and promotion.
Mol Download Chemical properties
CAS:
37312-62-2
MF:
ICl
MW:
0
EINECS:
253-457-5
MDL No.:
MFCD01775573
Symbol(GHS)
Signal word
Danger
Hazard statements
Precautionary statements
Xi'an Eastling biotech Co., Ltd. is dedicated to the research and development, production, and sales of natural plant extracts; With nearly 15 years of experience in identifying, researching, developing, and producing active ingredients for medicinal plants, we focus on providing innovative products and services to customers in industries such as pharmaceuticals, health food, and cosmetics.
Eastling Biotechnology has established a global direct harvesting system for plant raw materials, ensuring the high quality and authenticity of raw materials, while also protecting the continuity and diversity of plants; Having strong research and development capabilities, we can develop more effective and specialized plant active ingredients for the pharmaceutical, health food, and cosmetics industries; We have established an advanced quality control system, and the quality control of our products depends on advanced testing instruments and high-level technical experts. The effective combination of the two forms Eastling's ability to quickly and rigorously control product quality.
We have a production system that complies with Chinese GMP and American cGMP certifications, as well as advanced and optimized large-scale industrial production technology. In addition to producing specific products for Eastling Biotechnology, we also provide customized services to meet the characteristics and needs of different customers to produce customized products.
We believe that natural active ingredients are the foundation of our service to customers. Scientific and effective production technology is the foundation for us to provide customers with specialized products. We have the ability to serve customers in the pharmaceutical, health food, and cosmetics industries, provide new product solutions, and add new value to their products.